- Home
- EXEL vs TMQ Comparison
EXEL vs TMQ Comparison
Compare EXEL & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- TMQ
- Stock Information
- Founded
- EXEL 1994
- TMQ 2004
- Country
- EXEL United States
- TMQ Canada
- Employees
- EXEL N/A
- TMQ N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- TMQ Precious Metals
- Sector
- EXEL Health Care
- TMQ Basic Materials
- Exchange
- EXEL Nasdaq
- TMQ Nasdaq
- Market Cap
- EXEL 10.4B
- TMQ 249.6M
- IPO Year
- EXEL 2000
- TMQ N/A
- Fundamental
- Price
- EXEL $39.14
- TMQ $2.12
- Analyst Decision
- EXEL Buy
- TMQ
- Analyst Count
- EXEL 21
- TMQ 0
- Target Price
- EXEL $43.65
- TMQ N/A
- AVG Volume (30 Days)
- EXEL 2.2M
- TMQ 506.3K
- Earning Date
- EXEL 10-28-2025
- TMQ 10-07-2025
- Dividend Yield
- EXEL N/A
- TMQ N/A
- EPS Growth
- EXEL 81.76
- TMQ N/A
- EPS
- EXEL 2.08
- TMQ N/A
- Revenue
- EXEL $2,230,005,000.00
- TMQ N/A
- Revenue This Year
- EXEL $9.24
- TMQ N/A
- Revenue Next Year
- EXEL $13.04
- TMQ N/A
- P/E Ratio
- EXEL $18.75
- TMQ N/A
- Revenue Growth
- EXEL 10.73
- TMQ N/A
- 52 Week Low
- EXEL $25.17
- TMQ $0.47
- 52 Week High
- EXEL $49.62
- TMQ $2.19
- Technical
- Relative Strength Index (RSI)
- EXEL 54.38
- TMQ 69.60
- Support Level
- EXEL $38.37
- TMQ $1.78
- Resistance Level
- EXEL $39.27
- TMQ $2.19
- Average True Range (ATR)
- EXEL 0.98
- TMQ 0.13
- MACD
- EXEL 0.31
- TMQ 0.04
- Stochastic Oscillator
- EXEL 87.13
- TMQ 88.10
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.